CometReports
  • Home
  • Morning Updates
  • Earnings Outlook
  • Analysts Ratings
  • Stocks Review
No Result
View All Result
  • Home
  • Morning Updates
  • Earnings Outlook
  • Analysts Ratings
  • Stocks Review
No Result
View All Result
CometReports
No Result
View All Result

Axon Enterprise Inc. (NASDAQ: AXON) Now $83.01 Higher From Its Low (110.95), Does It Still Have A Growth Story?

Edison Carroll Edison by Edison Carroll Edison
May 26, 2023
in Technology and Energy
0

Axon Enterprise Inc. (NASDAQ:AXON) currently has a daily average trading volume of 1.16M but it saw 816393 shares traded on Thursday. With a market cap of 14.68B USD, stock’s current market price of $193.96 came rising about 0.60 while comparing to the previous closing price of $192.81. In past 52 weeks, the stock remained buoying in the range of price level as high as $229.95 and as low as $83.01. In the recent trading on the day, stock has struck highest price mark of $194.52 while lowest mark touched by it was $189.63.

25-cent Stock Takes $11T Commodities Sector Digital

One brilliantly-run technology firm has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. Best of all, this upstart technology firm is currently trading undiscovered — below 25-cents per share — so very, very few investors know about it yet! For investors… it's an early-stage opportunity in a company that's bringing the US$11T global commodities sector straight into the 21st century.

All the details are in the FREE online report you can get here.

Sponsored

Taking a look at 20-day trading activity of Axon Enterprise Inc. (AXON) gives us an average price of $206.98, while its current price level is -15.65% below from 52-week high level whereas it is 133.66% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $215.04 while that of 200 days or SMA-200 reads an average of $174.59. A closer look into the stock’s movement over the week reveals that its volatility is standing at 3.43% during that period while stretching the period over a month that increases to 3.86%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 38.53 which implies that the stock is in neutral territory.

Over the week, AXON’s stock price is moving -3.84% down while it is -10.26% when we observe its performance for the past one month. Year-to-date it is 16.89% up and over the past year, the stock is showing an upside performance of 109.55%.

The latest quarterly earnings report issued by the company was for quarter ended 3/30/2023, when its quarterly earnings per share (EPS) of $0.88 beat the consensus estimate of $0.53 for the same. For AXON, analysts are forecasting an EPS-growth rate of 43.40% for current year and estimate for EPS growth in next year is 19.10%. In next quarter, company is expected to be making quarterly sales of $373.23 million as analysts are expecting the sales for current fiscal year at $1.46 billion and seeing the company making $1.74 billion in sales next year. Moreover, analysts are in estimates of $350.53 million for current-quarter revenue.

Currently, Axon Enterprise Inc.’s total number of outstanding shares is 72.64M with 6.07% of that held by the insiders while 77.40% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at 2.30% and return on equity (ROE) at 10.80%. It has a price to earnings ratio (P/E ratio) of 103.01 while having a 51.92 of forward P/E ratio. Stock’s beta reads 0.92. Stock has a price to book (P/B) ratio of 10.04 while price to sale or P/S ratio amounts to 11.50. Its return on asset (ROA) is 5.60% on average.

As per SEC documents, American Funds Growth Fund of Ame sought 2,562,563 of company’s common stock of worth $539.96 million as per recent closing price of the stock. American Funds Growth Fund of Ame is not the only institutional holder which restructured its stake in Axon Enterprise Inc., as Vanguard Total Stock Market ETF picked 1,987,226 shares of worth $418.73 million to bring its holdings to a total of 4093.0 shares. In the most recent quarter, Vanguard Small Cap Index Fund came cutting its stake by -0.02% in the company and now holds 1.68 million or 2.30% of the company’s stake having worth of about 353.07 million.

Tags: AXONAxon Enterprise Inc.AXON stockNASDAQ:AXON
Previous Post

It’s Not A Fantasy To Think That D-Market Elektronik Hizmetler ve Ticaret A.S. (HEPS) Has Big Future Potential

Next Post

Analysts: Lightwave Logic Inc. (LWLG) Will Spike -102.95 By Next 12 Months

Edison Carroll Edison

Edison Carroll Edison

Next Post

Analysts: Lightwave Logic Inc. (LWLG) Will Spike -102.95 By Next 12 Months

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recent News

Should You Sell The AZEK Company Inc. (AZEK) And Go Away This Year?

June 8, 2023

Evelo Biosciences Inc. (NASDAQ: EVLO) Bulls Still Eyeing Towards $2.00

June 8, 2023

Aurinia Pharmaceuticals Inc. (AUPH) Down -21.73% From Its 52-Week High, But Growth Potential Is Changing Over Time

June 8, 2023

Neogen Corporation (NASDAQ: NEOG) Recovers 84.65% From 52-Week Low, Is NEOG Still A High-Risk, High-Reward Play?

June 8, 2023

ABOUT US
Become an active part of this community! We will be happy about any activity related to the transfer of your information experience. Write stories about your travels, share opinions about cities, countries and places of interest. Get answers to any questions related to news, scientific projects, travel and other things, and answer them yourself.

Categories

  • Morning Updates
  • Earnings Outlook
  • Analysts Ratings
  • Stocks Review
  • Business
  • Technology and Energy

Company

  • Home
  • About us
  • Contact Us

Recent Posts

  • Should You Sell The AZEK Company Inc. (AZEK) And Go Away This Year?
  • Evelo Biosciences Inc. (NASDAQ: EVLO) Bulls Still Eyeing Towards $2.00
  • Aurinia Pharmaceuticals Inc. (AUPH) Down -21.73% From Its 52-Week High, But Growth Potential Is Changing Over Time

Copyright © 2022 Comet Reports

No Result
View All Result
  • About us
  • Contact Us
  • Home

Copyright © 2022 Comet Reports